Acta Neuropathologica

, Volume 86, Issue 3, pp 275–284 | Cite as

CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle

  • D. Figarella-Branger
  • H. Moreau
  • J. F. Pellissier
  • N. Bianco
  • G. Rougon
Regular Papers


The expression of the CD24 molecule, a glycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts, was studied in developing nerve and muscle (after 16 weeks of gestation), normal adult and various diseased human muscles using immunohistochemistry and Western blot analysis. Immunohistochemical studies demonstrated that: (1) in developing muscles, fibers did not express CD24, whereas only some mesenchymal areas, also expressing neural cell adhesion molecule (N.CAM) and vimentin, and developing nerves were positive; (2) in normal adult muscles, CD24 immunoreactivity was observed only in some unmyelinated nerve fibers-intra and extra fusal muscle fibers, satellite cells and neuromuscular junctions were negative; and (3) in all diseased muscles studied here, CD24 expression was always associated with a subpopulation of regenerative fibers. These fibers also expressed vimentin, desmin, developmental myosin heavy chain, N.CAM and its polysialylated isoforms (PSA-N.CAM). The number of CD24-positive fibers was always lower than that of PSA-N.CAM-positive fibers. Denervated fibers and vacuolated muscle fibers never expressed CD24. Western blot analysis indicated that the apparent molecular mass of CD24 antigen was different between muscle and developing nervous tissues, suggesting that CD24 glycosylation is tissue specific. Since the molecule was not expressed in developing human muscle fibers, it strongly suggests that regenerative and fetal myotubes are different with respect to the CD24 molecule expression.

Key words

Cell surface glycoprotein Development Human muscle Regeneration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boisseau S, Nedelec J, Poirier V, Rougon G, Simonneau M (1991) Analysis of high PSA-N.CAM expression during mammalian spinal cord and peripheral nervous system development. Development 112: 69–82Google Scholar
  2. 2.
    Bornemann A, Schmalbruch H (1992) Desmin and vimentin in regenerating muscles. Muscle Nerve 15: 14–20Google Scholar
  3. 3.
    Brocks L, Jap PHK, Ramaekers FCS, Stadhouders AM (1991) Vimentin and desmin expression in degenerating and regenerating dystrophic muscles. Virchows Arch [B] 61: 89–96Google Scholar
  4. 4.
    Carlsson M, Nilsson K (1989) Reactivity of workshop B-cell antibodies with B-CLL cells induced to differentiate with or without concomitant proliferation. In: W Knapp, et al (eds) Leucocyte typing IV. Oxford University Press, Oxford, pp 206–218Google Scholar
  5. 5.
    Cashman N, Covault J, Wollman R, Sanes J (1987) Neural cell adhesion molecule in normal, denervated and myopathic human muscle. Ann Neurol 21: 481–489Google Scholar
  6. 6.
    Cossu G, Molinaro M (1987) Cell heterogeneity in the myogenic lineage. Curr Top Dev Biol 23: 185–208Google Scholar
  7. 7.
    Covault J, Merlie JP, Goridis C, Sanes JR (1986) Molecular forms of N.CAM and its RNA in developing and denervated skeletal muscle. J Cell Biol 102: 731–739Google Scholar
  8. 8.
    Cros D, Pearson C, Verity MA (1980) Polymyositis-Dermatomyositis. Diagnosis and prognostic significance of muscle alkaline phosphatase. Am J Pathol 101: 159–176Google Scholar
  9. 9.
    Draeger A, Weeds AG, Fitzsimons B (1987) Primary, secondary and tertiary myotubes in developing skeletal muscle: a new approach to the analysis of human myogenesis. J Neurol Sci 81: 19–43Google Scholar
  10. 10.
    Engel P, Ingles J, Gallart T, Vives J (1987) Changes in the expression of B cell surface antigen detected by the workshop CD 24 monoclonal antibodies following in vitro activation. In: McMichael AJ, et al (eds) Leucocyte typing III. Oxford University Press, Oxford, pp 368–382Google Scholar
  11. 11.
    Figarella-Branger D, Nedelec J, Pelissier JF, Boucraut J, Bianco N, Rougon G (1990) Expression of various isoforms of neural cell adhesion molecules and their highly polysialylated counterparts in diseased human muscles. J Neurol Sci 98: 21–36Google Scholar
  12. 12.
    Figarella-Branger D, Pellissier JF, Bianco N, Pons F, Leger JJ; Rougon G (1992) Expression of various N.CAM isoforms in human embryonic muscles: correlation with myosin heavy chain phenotypes. J Neurol Exp Pathol 51: 12–23Google Scholar
  13. 13.
    Figarella-Branger D, Calore EE, Boucraut J, Bianco N, Rougon G and Pellissier JF (1992) Expression of cell surface and cytoskeleton developmentally regulated proteins in adult centronuclear myopathies. J Neurol Sci 109: 69–76Google Scholar
  14. 14.
    Hartley RS, Brandman E, Yablonka-Reuveni Z (1991) Myoblasts from fetal and adult skeletal muscle regulate myosin expression differently. Dev Biol 148: 249–260Google Scholar
  15. 15.
    Kay R, Takei F, Humphries RK (1990) Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens. J Immunol 145: 1952–1959Google Scholar
  16. 16.
    Kay R, Rosten PM, Humphries RK (1991) CD 24, a signal transducer modulating B cell activation response, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol 147: 1412–1416Google Scholar
  17. 17.
    Ling NR, Maclennan ICM, Mason DY (1987) B-cell and plasma cell antigens: new and previously defined clusters. In: McMichael AJ, et al (eds) Leucocyte typing III. Oxford University Press, Oxford, pp 302–315Google Scholar
  18. 18.
    Linton PJ, Decker DJ, Klinman NR (1989) Primary antibodyforming cells and secondary B cells are generated from separate precursor cell subpopulations. Cell 59: 1049–1059Google Scholar
  19. 19.
    Marini JF, Pons F, Anoal F, Fardeau M, Léger JJ (1990) Immunocytochemical study of myosin changes in muscle fibers of DMD boys and symptomatic carriers of DMD identified by antidystrophin monoclonal antibodies (abstract). J Neurol Sci 98: 420Google Scholar
  20. 20.
    Miller JB (1992) Myoblast diversity in skeletal myogenesis: how much and to what end? Cell 69: 1–3Google Scholar
  21. 21.
    Mittler RS, Talle MA, Carpenter K, Rao PE, Goldstein G (1983) Generation and characterization of monoclonal antibodies reactive with human B lymphocytes. J Immunol 131: 1754–1761Google Scholar
  22. 22.
    Montarras D, Chelly J, Bober E, Arnold H, Ott MO, Gros F, Pinset C (1991) Developmental pattern in the expression of myf 5, myo D, myogenin, and mrf4 during myogenesis. New Biologist 3: 592–600Google Scholar
  23. 23.
    Nedelec J, Pierres M, Moreau H, Barbet J, Naquet P, Faivre-Sarrailh C, Rougon G (1992) Isolation and characterization of a novel glycosyl-phosphatidyl inositol anchored glycoconjugate expressed by developing neurons. Eur J Biochem 203: 433–442Google Scholar
  24. 24.
    Pezzutto A, Behur F, Callard RE (1989) Flow cytometry analysis of the B-cell panel: joint report. In: Knapp W, et al (eds) Leucocyte typing IV. Oxford University Press, Oxford, pp 165–181Google Scholar
  25. 25.
    Pirruccello ST, Lebien TW (1986) The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol 136: 3779–3784Google Scholar
  26. 26.
    Pons F, Leger J, Chevallay M, Tomé FMS, Fardeau M, Léger JJ (1986) Immunocytochemical analysis of myosin heavy chain in human fetal skeletal muscles. J Neurol Sci 76: 151–163Google Scholar
  27. 27.
    Rougon G, Marshak D (1986) Structural and immunological characterization of the amino-terminal domain of mammalian neural cell adhesion molecules. J Biol Chem 261: 3396–3401Google Scholar
  28. 28.
    Rougon G, Deagostini-Bazin H, Hirn M, Goridis C (1982) Tissue and developmental stage specific forms of a neural cell surface antigen linked to differences in glycosylation of a common polypeptide. EMBO J 1: 1239–1244Google Scholar
  29. 29.
    Rougon G, Dubois C, Buckley N, Magnani J, Zollinger W (1986) A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N.CAM. J Cell Biol 103: 2429–2437Google Scholar
  30. 30.
    Rougon G, Alterman LA, Dennis K, Guo XJ, Kinnon C (1991) The murine heat-stable antigen: a different antigen expressed in both the hematolymphoid and neural cell lineages. Eur J Immunol 21: 1397–1402Google Scholar
  31. 31.
    Sarnat HB (1990) Myotubular myopathy: arrest of morphogenesis of myofibers associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. Can J Neurol Sci 17: 109–123Google Scholar
  32. 32.
    Stockinger H, Majdic O, Koller U, Knapp M (1987) Subclustering of the CD24 cluster. In: McMichael AJ, et al (eds) Leucocyte typing III. Oxford University Press, Oxford, pp 367–375Google Scholar
  33. 33.
    Vater R, Cullen MJ, Nicholson LVB, Harris JB (1992) The fate of desmin and titin during the degeneration and regeneration of the soleus muscle of the rat. Acta Neuropathol 84: 278–288Google Scholar
  34. 34.
    Walsh F, Moore S (1985) Expression of cell adhesion molecule N.CAM in diseases of human adult skeletal muscle. Neurosci Lett 59: 73–78Google Scholar
  35. 35.
    Wang CY, Azzo W, Al-Katib A, Chiorrazzi N, Knowles DM (1984) Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human lymphocytes. J Immunol 133: 684–688Google Scholar
  36. 36.
    Yablonka-Reuveni Z, Maneroff M (1990) Temporal differences in desmin expression between myoblasts from embryonic and adult chicken skeletal muscle. Differentiation 45: 21–28Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • D. Figarella-Branger
    • 1
    • 2
  • H. Moreau
    • 1
  • J. F. Pellissier
    • 2
  • N. Bianco
    • 2
  • G. Rougon
    • 1
  1. 1.Biologie de la Différenciation Cellulaire, CNRS URA 179, case 901Université de LuminyMarseille Cedex 9France
  2. 2.Laboratoire de Biopathologie Nerveuse et MusculaireFaculté de Médecine TimoneMarseille Cedex 5France

Personalised recommendations